Question 1

How many shares of EIGR does UBS Group AG own?

Accepted Answer

UBS Group AG previously held 0 shares of EIGR (EIGER BIOPHARMACEUTICALS INC) before exiting the position in 2024-Q1.

Question 2

What is UBS Group AG's EIGR position worth?

Accepted Answer

UBS Group AG's EIGR position was last reported at $0 in 2024-Q1 before the exit.

Question 3

Is UBS Group AG buying or selling EIGR?

Accepted Answer

In 2024-Q1, UBS Group AG exited their EIGR position entirely (-100.0% change in shares).

Question 4

When did UBS Group AG first buy EIGR?

Accepted Answer

Based on available 13F filings, UBS Group AG first reported a position in EIGR in 2019-Q1. They have held the position across 21 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2024-Q1 Latest	Exited	0	-100.0%	$0	0.0%	—	0
2023-Q4	Increased	11,045	+193x	$2,485	0.0%	—	14
2023-Q3	Increased	57	+1040.0%	$18	0.0%	—	12
2023-Q2	Decreased	5	-100.0%	$4	0.0%	—	0
2023-Q1	Decreased	13,597	-14.2%	$12,197	0.0%	—	0
2022-Q4	Increased	15,850	+223.6%	$18,703	0.0%	—	20
2022-Q3	Decreased	4,898	-25.7%	$37,000	0.0%	—	0
2022-Q2	Decreased	6,593	-50.1%	$42,000	0.0%	—	0
2022-Q1	Increased	13,209	+0.9%	$110,000	0.0%	—	15
2021-Q4	Increased	13,086	+245.6%	$68,000	0.0%	—	23
2021-Q3	Increased	3,786	+62.7%	$25,000	0.0%	—	19
2021-Q2	Decreased	2,327	-4.8%	$20,000	0.0%	—	0
2021-Q1	Decreased	2,443	-97.2%	$22,000	0.0%	—	0
2020-Q4	Increased	88,087	+10.6%	$1.1M	0.0%	—	28
2020-Q3	Decreased	79,669	-11.3%	$648,000	0.0%	—	0
2020-Q2	Increased	89,785	+31.1%	$862,000	0.0%	—	32
2020-Q1	Increased	68,481	+150.5%	$466,000	0.0%	—	39
2019-Q4	Increased	27,341	+59.8%	$407,000	0.0%	—	34
2019-Q3	Increased	17,111	+3288.3%	$175,000	0.0%	—	36
2019-Q2	Unchanged	505	0.0%	$5,000	0.0%	—	0
2019-Q1	New	505	-	$7,000	0.0%	—	25

EIGR21 quarters

EIGR
21 quarters